c-Abl Mediates α-Synuclein Toxicity: A Promising Therapeutic Target in Parkinson's Disease and α-Synucleinopathies

被引：0
|
作者：
Brahmachari, S. [1 ,2 ,3 ]
Mao, X. [1 ,2 ,3 ]
Karuppagounder, S. S. [1 ,2 ,3 ]
Lee, Y. [1 ,2 ,3 ]
Dawson, V. L. [1 ,2 ,3 ,4 ,5 ,6 ]
Ko, H. S. [1 ,2 ,7 ]
Dawson, T. M. [1 ,2 ,6 ,7 ]
机构：
[1] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD USA
[2] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA
[3] Adrienne Helis Malvin Med Res Fdn, New Orleans, LA USA
[4] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Stem Cell Programs, Baltimore, MD USA
[5] Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA
[6] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD USA
[7] Diana Helis Henry Med Res Fdn, New Orleans, LA USA
来源：
CELL TRANSPLANTATION | 2014年 / 23卷 / 06期
关键词：
D O I：
暂无
中图分类号：
Q813 [细胞工程];
学科分类号：
摘要：
引用
收藏
页码：764 / 764
页数：1
相关论文
共 50 条
  • [41] The c-Abl inhibitor, Nilotinib, protects dopaminergic neurons in a preclinical animal model of Parkinson's disease
    Karuppagounder, Senthilkumar S.
    Brahmachari, Saurav
    Lee, Yunjong
    Dawson, Valina L.
    Dawson, Ted M.
    Ko, Han Seok
    SCIENTIFIC REPORTS, 2014, 4
  • [42] α-Synuclein: Membrane Interactions and Toxicity in Parkinson's Disease
    Auluck, Pavan K.
    Caraveo, Gabriela
    Lindquist, Susan
    ANNUAL REVIEW OF CELL AND DEVELOPMENTAL BIOLOGY, VOL 26, 2010, 26 : 211 - 233
  • [43] Discovery of conformationally constrained c-Abl inhibitors with potential neuroprotective effects against Parkinson's disease
    Yang, Zichao
    Ai, Yangcheng
    Wu, Guowu
    Guo, Fengqiu
    Yang, Zilong
    Cheng, Beijun
    Zhang, Lishun
    Li, Mingxia
    Chen, Jianjun
    Zhang, Jiajie
    Zhang, Tingting
    BIOORGANIC & MEDICINAL CHEMISTRY, 2023, 96
  • [44] The c-Abl inhibitor, Nilotinib, protects dopaminergic neurons in a preclinical animal model of Parkinson's disease
    Senthilkumar S. Karuppagounder
    Saurav Brahmachari
    Yunjong Lee
    Valina L. Dawson
    Ted M. Dawson
    Han Seok Ko
    Scientific Reports, 4
  • [45] α-Synuclein: A Promising Biomarker for Parkinson's Disease and Related Disorders
    Hatano, Taku
    Okuzumi, Ayami
    Matsumoto, Gen
    Tsunemi, Taiji
    Hattori, Nobutaka
    JOURNAL OF MOVEMENT DISORDERS, 2024, 17 (02) : 127 - 137
  • [46] Altered Subcellular Distribution of c-Abl in Alzheimer's Disease
    Jing, Zheng
    Caltagarone, John
    Bowser, Robert
    JOURNAL OF ALZHEIMERS DISEASE, 2009, 17 (02) : 409 - 422
  • [47] Exosomal α-synuclein in Multiple System Atrophy and Parkinson's Disease Cause Distinct Synucleinopathies
    Chi, X.
    Kou, L.
    Sun, Y.
    Xia, Y.
    Wang, T.
    MOVEMENT DISORDERS, 2023, 38 : S63 - S63
  • [48] Targeting α-synuclein as a therapeutic strategy for Parkinson's disease
    Lawand, Nada B.
    Saade, Nayef E.
    El-Agnaf, Omar M.
    Safieh-Garabedian, Bared
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2015, 19 (10) : 1351 - 1360
  • [49] c-Abl tyrosine kinase down-regulation as target for memory improvement in Alzheimer's disease
    Leon, Rilda
    Gutierrez, Daniela A.
    Pinto, Claudio
    Morales, Cristian
    de la Fuente, Catalina
    Riquelme, Cristobal
    Cortes, Bastian I.
    Gonzalez-Martin, Adrian
    Chamorro, David
    Espinosa, Nelson
    Fuentealba, Pablo
    Cancino, Gonzalo I.
    Zanlungo, Silvana
    Dulcey, Andres E.
    Marugan, Juan J.
    Rojas, Alejandra Alvarez
    FRONTIERS IN AGING NEUROSCIENCE, 2023, 15
  • [50] Inhibitors of α-synuclein oligomerization and toxicity:: a future therapeutic strategy for Parkinson's disease and related disorders
    Amer, Dena A. M.
    Irvine, G. Brent
    El-Agnaf, Omar M. A.
    EXPERIMENTAL BRAIN RESEARCH, 2006, 173 (02) : 223 - 233
12345